The interrelationship of complement‐activation fragments and angiogenesis‐related factors in early pregnancy and their association with pre‐eclampsia

doi:10.1111/j.1471-0528.2009.02473.x

Epidemiology

You have full text access to this OnlineOpen article

The interrelationship of complement-activation fragments and angiogenesis-related factors in early pregnancy and their association with pre-eclampsia

AM Lynch¹,
JR Murphy²,
RS Gibbs¹,
RJ Levine³,
PC Giclas⁴,
JE Salmon⁵,
VM Holers⁶

Article first published online: 14 JAN 2010

DOI: 10.1111/j.1471-0528.2009.02473.x

Issue

BJOG: An International Journal of Obstetrics & Gynaecology

Volume 117, Issue 4, pages 456–462, March 2010

Additional Information

How to Cite

Lynch, A., Murphy, J., Gibbs, R., Levine, R., Giclas, P., Salmon, J. and Holers, V. (2010), The interrelationship of complement-activation fragments and angiogenesis-related factors in early pregnancy and their association with pre-eclampsia. BJOG: An International Journal of Obstetrics & Gynaecology, 117: 456–462. doi: 10.1111/j.1471-0528.2009.02473.x

Author Information

¹
Department of Obstetrics and Gynecology, University of Colorado Denver School of Medicine, Aurora, CO, USA
²
National Jewish Health, Denver, CO, USA
³
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, USA
⁴
Department of Pediatrics, Division of Allergy and Immunology, National Jewish Health, Denver, CO, USA
⁵
Weill Cornell Medical Center, Hospital for Special Surgery, New York, NY, USA
⁶
Division of Rheumatology, Departments of Medicine and Immunology, University of Colorado Denver School of Medicine, Aurora, CO, USA

^*Dr A Lynch, Department of Obstetrics and Gynecology, University of Colorado Denver School of Medicine, Mail Stop B198, 12631 East 17th Avenue, Aurora, CO 80045, USA. Email anne.lynch@ucdenver.edu

Publication History

Issue published online: 8 FEB 2010
Article first published online: 14 JAN 2010
Accepted 18 November 2009. Published Online 14 January 2010.

ARTICLE TOOLS

View Full Article (HTML) Get PDF (209K)

References

1
Ilekis JV, Reddy UM, Roberts JM. Preeclampsia – a pressing problem: an executive summary of a National Institute of Child Health and Human Development workshop. Reprod Sci 2007;14:508–23.
2
Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672–83.
3
Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006;355:992–1005.
4
Maynard S, Epstein FH, Karumanchi SA. Preeclampsia and angiogenic imbalance. Annu Rev Med 2008;59:61–78.
5
Dekker G, Robillard PY. Pre-eclampsia: is the immune maladaptation hypothesis still standing? An epidemiological update. J Reprod Immunol 2007;76:8–16.
6
Parham P. NK cells and trophoblasts: partners in pregnancy. J Exp Med 2004;200:951–5.
7
Lynch AM, Murphy JR, Byers T, Gibbs RS, Neville MC, Giclas PC, et al. Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia. Am J Obstet Gynecol 2008;198:3851–9.
8
Holers VM, Girardi G, Mo L, Guthridge JM, Molina H, Pierangeli SS, et al. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 2002;195:211–20.
9
Salmon JE, Girardi G, Holers VM. Complement activation as a mediator of antiphospholipid antibody induced pregnancy loss and thrombosis. Ann Rheum Dis 2002;61:ii46–50.
- PubMed,
- CAS
10
Holers VM, Thurman JM. The alternative pathway of complement in disease: opportunities for therapeutic targeting. Mol Immunol 2004;41:147–52.
- Web of Science® Times Cited: 39
11
Markiewski MM, Lambris JD. The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am J Pathol 2007;171:715–27.
12
Walport MJ. Complement. First of two parts. N Engl J Med 2001;344:1058–66.
13
Walport MJ. Complement. Second of two parts. N Engl J Med 2001;344:1140–4.
14
Morgan BP, Holmes CH. Immunology of reproduction: protecting the placenta. Curr Biol 2000;10:R381–3.
15
Pijnenborg R, Vercruysse L, Hanssens M. Fetal–maternal conflict, trophoblast invasion, preeclampsia, and the red queen. Hypertens Pregnancy 2008;27:183–96.
16
Holers VM. The spectrum of complement alternative pathway-mediated diseases. Immunol Rev 2008;223:300–16.
Direct Link:
17
Sjoberg AP, Trouw LA, Blom AM. Complement activation and inhibition: a delicate balance. Trends Immunol 2009;30:83–90.
18
Girardi G, Yarilin D, Thurman JM, Holers VM, Salmon JE. Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J Exp Med 2006;203:2165–75.
19
Lynch AM, Gibbs RS, Murphy JR, Byers T, Neville MC, Giclas PC, et al. Complement activation fragment Bb in early pregnancy and spontaneous preterm birth. Am J Obstet Gynecol 2008;199:354e1–8.
20
Villar J, Carroli G, Wojdyla D, Abalos E, Giordano D, Ba’aqeel H, et al. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? Am J Obstet Gynecol 2006;194:921–31.
21
Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:785–99.
- PubMed,
- Web of Science® Times Cited: 522
22
Lubchenco LO, Hansman C, Boyd E. Intrauterine growth in length and head circumference as estimated from live births at gestational ages from 26 to 42 weeks. Pediatrics 1966;37:403–8.
23
Smith GC, Crossley JA, Aitken DA, Jenkins N, Lyall F, Cameron AD, et al. Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth. Obstet Gynecol 2007;109:1316–24.
24
Thadhani R, Mutter WP, Wolf M, Levine RJ, Taylor RN, Sukhatme VP, et al. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab 2004;89:770–5.
25
Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 2008;21:9–23.
26
Taylor RN, Grimwood J, Taylor RS, McMaster MT, Fisher SJ, North RA. Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol 2003;188:177–82.
27
Tidwell SC, Ho HN, Chiu WH, Torry RJ, Torry DS. Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am J Obstet Gynecol 2001;184:1267–72.
28
Rana S, Karumanchi SA, Levine RJ, Venkatesha S, Rauh-Hain JA, Tamez H, et al. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. Hypertension 2007;50:137–42.
29
Challier JC, Basu S, Bintein T, Minium J, Hotmire K, Catalano PM, et al. Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta 2008;29:274–81.
30
Choy LN, Rosen BS, Spiegelman BM. Adipsin and an endogenous pathway of complement from adipose cells. J Biol Chem 1992;267:12736–41.
31
Zhang J, Wright W, Bernlohr DA, Cushman SW, Chen X. Alterations of the classic pathway of complement in adipose tissue of obesity and insulin resistance. Am J Physiol Endocrinol Metab 2007;292:E1433–40.
32
Walker UA, Kirschfink M, Peter HH. Improvement of acquired partial lipodystrophy with rosiglitazone despite ongoing complement activation. Rheumatology (Oxford) 2003;42:393–4.
33
Pattrick M, Luckett J, Yue L, Stover C. Dual role of complement in adipose tissue. Mol Immunol 2009;46:755–60.
34
Savage DB, Semple RK, Clatworthy MR, Lyons PA, Morgan BP, Cochran EK, et al. Complement abnormalities in acquired lipodystrophy revisited. J Clin Endocrinol Metab 2009;94:10–6.
35
Jeyabalan A, Powers RW, Durica AR, Harger GF, Roberts JM, Ness RB. Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia. Am J Hypertens 2008;21:943–7.
36
Suwaki N, Masuyama H, Nakatsukasa H, Masumoto A, Sumida Y, Takamoto N, et al. Hypoadiponectinemia and circulating angiogenic factors in overweight patients complicated with pre-eclampsia. Am J Obstet Gynecol 2006;195:1687–92.
37
Silver RM. Immune activation early in pregnancy: trouble down the road? Am J Obstet Gynecol 2008;199:327–8.

View Full Article (HTML) Get PDF (209K)

JOURNAL TOOLS

JOURNAL MENU

FIND ISSUES

FIND ARTICLES

GET ACCESS

FOR CONTRIBUTORS

ABOUT THIS JOURNAL

SPECIAL FEATURES

The interrelationship of complement-activation fragments and angiogenesis-related factors in early pregnancy and their association with pre-eclampsia

BJOG: An International Journal of Obstetrics & Gynaecology

How to Cite

Author Information

Publication History

ARTICLE TOOLS

References

More content like this

JOURNAL TOOLS

JOURNAL MENU

FIND ISSUES

FIND ARTICLES

GET ACCESS

FOR CONTRIBUTORS

ABOUT THIS JOURNAL

SPECIAL FEATURES

The interrelationship of complement-activation fragments and angiogenesis-related factors in early pregnancy and their association with pre-eclampsia

BJOG: An International Journal of Obstetrics & Gynaecology

How to Cite

Author Information

Publication History

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

References

More content like this